Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trialsThe Lancet (British edition), 2023-04, Vol.401 (10384), p.1277-1292 [Peer Reviewed Journal]2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00285-4 ;PMID: 37061269Full text available |
|
2 |
Material Type: Article
|
Scientific advisory councils in the COVID-19 responseThe Lancet (British edition), 2024-02, Vol.403 (10426), p.510-512 [Peer Reviewed Journal]2024 Elsevier Ltd ;2024. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)01846-9 ;PMID: 37839418Full text available |
|
3 |
Material Type: Article
|
Achieving universal health coverage in France: policy reforms and the challenge of inequalitiesThe Lancet (British edition), 2016-05, Vol.387 (10034), p.2236-2249 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 28, 2016 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)00580-8 ;PMID: 27145707 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
France's COVID-19 response: balancing conflicting public health traditionsThe Lancet, 2020-07, Vol.396 (10246), p.219-221 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31599-3 ;PMID: 32682489Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Recognising Italy's mistakes in the public health response to COVID-19The Lancet (British edition), 2022-01, Vol.399 (10322), p.357-358 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02805-1 ;PMID: 35065781Full text available |
|
6 |
Material Type: Article
|
Mobilising experience from Ebola to address plague in Madagascar and future epidemicsThe Lancet (British edition), 2017-12, Vol.390 (10113), p.2624-2625 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright Elsevier Limited Dec 16, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)33088-X ;PMID: 29195687Full text available |
|
7 |
Material Type: Article
|
From (re-)framing NCDs to shaping public health policies on NCDs and communicable diseasesThe Lancet (British edition), 2017-10, Vol.390 (10105), p.1830-1831 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright Elsevier Limited Oct 21, 2017 ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32419-4 ;PMID: 29082874Full text available |